|
Delayed
Toronto S.E.
20:22:37 10/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0600 CAD | +20.00% |
|
-.--% | -40.00% |
| Market Cap | 337K 241K 215K 198K 180K 22.85M 344K 2.36M 952K 12.06M 906K 887K 38.09M | P/E 2024 * |
-
| P/E 2025 | -2.96x |
|---|---|---|---|---|---|
| Enterprise Value | 337K 241K 216K 198K 180K 22.85M 344K 2.36M 952K 12.06M 906K 887K 38.1M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
59.29% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +20.00% | ||
| 3 months | -25.00% | ||
| Current year | -40.00% |
| Current year | 0.05 | 0.1 | |
| 1 year | 0.05 | 0.1 | |
| 3 years | 0 | 0.1 | |
| 5 years | 0 | 0.14 | |
| 10 years | 0 | 0.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harry Katevatis
CEO | Chief Executive Officer | 84 | 10/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Harry Katevatis
BRD | Director/Board Member | 84 | 10/03/2019 |
Vivian Katsuris
BRD | Director/Board Member | 61 | 14/03/2019 |
| Director/Board Member | 62 | 30/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/05/20 | NGN Biomed Opportunity II LP
| Sell | Company | 125,000 | 2.7778% | |
| 07/05/20 | NGN Biomed Opportunity II LP
| Other | Company | 0 | 0% | - |
| 07/05/20 | NGN Biomed Opportunity II LP
| Sell | Company | 25,000 | 0.5556% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +20.00% | -.--% | +20.00% | -42.86% | 181K | ||
| +0.21% | +1.99% | +33.46% | +102.90% | 132B | ||
| +0.57% | +2.34% | +32.44% | +79.00% | 22.89B | ||
| +0.71% | +1.42% | +25.70% | +56.20% | 17.14B | ||
| -2.78% | +1.33% | +17.19% | +153.92% | 16.07B | ||
| +0.95% | +2.35% | +16.45% | +26.34% | 14.69B | ||
| +1.25% | +3.25% | -7.87% | +6.88% | 14.08B | ||
| -0.50% | -1.43% | +21.12% | +35.74% | 12.22B | ||
| +1.42% | -7.24% | -15.77% | +54.03% | 11.98B | ||
| -2.60% | +1.93% | +49.94% | +63.66% | 11.31B | ||
| Average | +1.94% | +1.07% | +19.27% | +53.58% | 25.26B | |
| Weighted average by Cap. | +0.16% | +2.34% | +26.32% | +83.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -184K -132K -118K -108K -98.37K -12.5M -188K -1.29M -521K -6.6M -495K -485K -20.83M | -71.29K -51.02K -45.55K -41.8K -38.02K -4.83M -72.71K -499K -201K -2.55M -191K -187K -8.05M |
| Net Debt | -6.67K -4.78K -4.26K -3.91K -3.56K -452K -6.81K -46.73K -18.84K -239K -17.92K -17.54K -754K | 68 48.67 43.45 39.87 36.27 4.61K 69.35 476.23 191.97 2.43K 182.65 178.76 7.68K |
Employees
-
Sector
Investment Holding Companies
- Stock Market
- Stocks
- ZENI.P Stock
Select your edition
All financial news and data tailored to specific country editions
















